reported that antibodies targeting the C‐terminus of ERG exhibit 88% sensitivity and 88% specificity for identifying ERG rearrangements in Ewing sarcomas harboring the EWSR1::ERG fusion [33]. The gene discussed is ERG; the disease is Ewing sarcoma.